Follow The Filings

EMBC Embecta

Embecta earnings company data as of 4:49 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 24 Nov EPS 0.31 — —
Rev — — —

Insider trades

Open-market buys and sales by EMBC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All EMBC insider trades
  • $558K bought by 4 insiders
  • $37K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Milton Mayo Morris Director
    Sale
    $37K 6,293 shares at $5.88 11% of stake
    Traded Sep 4 Filed Sep 8
    ↗
  2. Devdatt Kurdikar CEO
    Buy
    $141K 30,000 shares at $4.70 +3.9% to stake
    Traded Aug 12 Filed Aug 13
    ↗
  3. Jacob Elguicze CFO
    Buy
    $93K 20,000 shares at $4.67 +6.9% to stake
    Traded Aug 12 Filed Aug 13
    ↗
  4. Jeffrey Z Mann Pres, Pharm Svc&Prod Mgmt, CLO
    Buy
    $100K 20,000 shares at $4.99 +8.2% to stake
    Traded Aug 12 Filed Aug 13
    ↗
  5. Robert J. Hombach Director
    Buy
    $224K 45,000 shares at $4.97 +70% to stake
    Traded Aug 12 Filed Aug 13
    ↗

Also filed in the last 12 months, not counted as buying or selling: 17 stock grants and 7 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K/A 9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.01,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
DEFA14A SCHEDULE 14A Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.